Quotient Therapeutics
PrivateLast Round
Corporate Funding
Mar 24, 2026
Total Funding Raised
$120M
Company Overview
Quotient Therapeutics operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Corporate Funding round in March 2026.
Quotient Therapeutics is a biotechnology company that utilizes a somatic genomics platform to discover genetically validated targets and develop transformative therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Quotient Therapeutics Comparables
Compare Quotient Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ProFound Therapeutics | 83% | |
| Character Biosciences | 81% | |
| Mirador Therapeutics | 81% |
For institutional investors. Book with your work email.
Quotient Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Mar 24, 2026 | ||||
| Series A | Nov 21, 2023 | ||||
| Seed | Nov 21, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Quotient Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Flagship Pioneering | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 24, 2026
Multi-year agreement to discover drug targets for inflammatory bowel disease.
- Apr 29, 2025
Rahul Kakkar, M.D. joins as Chief Executive Officer.
For institutional investors. Book with your work email.
Quotient Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Quotient Therapeutics's valuation, stock price, and market status.
Is Quotient Therapeutics a public or private company?
Quotient Therapeutics is a private company.
What is the current stock price of Quotient Therapeutics?
Quotient Therapeutics is a private company, so its shares have no public market price. Caplight tracks Quotient Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Quotient Therapeutics worth (valuation)?
Valuation information for Quotient Therapeutics is not publicly available.
Can I buy Quotient Therapeutics stock?
Quotient Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Quotient Therapeutics's last funding round?
Quotient Therapeutics's most recent funding round was Corporate Funding on March 24, 2026.
Who are the main investors in Quotient Therapeutics?
Key investors in Quotient Therapeutics include Flagship Pioneering.
Will Quotient Therapeutics IPO soon?
No public IPO plans have been announced for Quotient Therapeutics.
How can I track Quotient Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Quotient Therapeutics's shares on secondary markets.